Public Policy Summit

THANK YOU FOR ATTENDING THE 8th Annual Public Policy Summit

Midpoint of the Decade of the Kidney™: Re-Prioritizing Patients Across Policy, Regulatory, and Payment Decisions

About the Public Policy Summit: The AAKP Public Policy Summit is hosted annually by the American Association of Kidney Patients (AAKP), the nation’s oldest and largest independent kidney patient organization. The event informs policymakers and influencers of specific barriers confronting kidney patients and their care choices as well as challenges faced by innovation leaders working to advance new medical diagnostics, drugs, and devices. Speakers include kidney patient consumers along with elected and appointed leaders, kidney health and organ transplant experts, industry leaders, researchers and other stakeholders. The Summit emphasizes core AAKP initiatives, such as KidneyVoter™ and Patient Voice Patient Choice™, as channels for the organized voices of patients to impact future kidney policies.

Since its launch in 2018, the Summit has served as a forum to organize support for major policy changes including the inclusion of living organ donors under the Family Medical Leave Act (2018), the Trump Administration’s Executive Order on Advancing American Kidney Health (2019), and the extension of federal immunosuppressive drug coverage to ensure long-term transplant survival (2020). In recent years, the Policy Summit has been a vital platform to spotlight Government Determinants of Health (GDOH) – federal regulatory and payment decisions that impede the lives and livelihoods of kidney patients and further burden American taxpayers.

About the 2025 Public Policy Summit: 2025 is the midpoint of the AAKP-led Decade of the Kidney™, a ten-year drive to transcend high-cost, high mortality status quo kidney care through greater innovation and increased opportunities for transplantation. This year’s Public Policy Summit will highlight common sense solutions that: re-prioritize patients within federal kidney policy decisions, help slow disease progression, improve patient health and transplant readiness, better protect living organ donors, and increase attention on long-term transplant patient survival.